Back to Journals » Patient Related Outcome Measures » Volume 5

Long-term safety and efficacy of natalizumab in relapsing-remitting multiple sclerosis: impact on quality of life

Total article views   HTML views PDF downloads Totals
24,229 Dovepress* 10,706+ 2,178 12,884
PubMed Central* 13,523 1,353 14,876
Totals 24,229 3,531 27,760
*Since 4 April 2014
+Since July 2016
Total mentioned Facebook Delicious Reddit Twitter Others
8 0 0 0 3 5

View citations on PubMed and Google Scholar